Vertex Pharmaceuticals Business Development Manager Salary
The average Vertex Pharmaceuticals Business Development Manager earns an estimated $163,791 annually, which includes an estimated base salary of $136,291 with a $27,500 bonus. Vertex Pharmaceuticals' Business Development Manager compensation is $31,651 more than the US average for a Business Development Manager. Business Development Manager salaries at Vertex Pharmaceuticals can range from $135,000 - $202,500.
The Business Development Department at Vertex Pharmaceuticals earns $4,744 more on average than the Finance Department.
Last updated 9 months ago.
- $136,291
- avg. base
- $27,500
- avg. bonus
Business Development Manager Salaries at Vertex Pharmaceuticals
Business Development Managers earn $78,418 more than Account Managers, and $569 less than Business Development Managers.
Compensation at Vertex Pharmaceuticals by Department
The Business Development Department averages $4,744 more than the Finance Department, and $3,938 less than the Marketing Department
Business Development Manager Compensation by Gender (All Companies)
The average female Business Development Manager at companies similar size to Vertex Pharmaceuticals reported making $126,047, while the average male Business Development Manager at similar sized companies reported making $134,824.
Business Development Manager Compensation by Ethnicity (All Companies)
The average Native American Business Development Manager at companies similar size to Vertex Pharmaceuticals reported making $195,000, while the average African American/Black Business Development Manager at similar sized companies reported making $88,600.
How Business Development Managers at Vertex Pharmaceuticals Rate Their Compensation
The majority of Business Development Managers at Vertex Pharmaceuticals believe they're compensated fairly. 100% of Business Development Managers at Vertex Pharmaceuticals say they receive annual bonuses, and the vast majority (96%) are satisfied with their benefits. See more compensation ratings at Vertex Pharmaceuticals
